United States - English - NLM (National Library of Medicine)

natural health supply - crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956) - indications: to be used for acute self-limiting conditions according to standard homeopathic indications purpose: fever vomiting

United States - English - NLM (National Library of Medicine)

rubimed ag - crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), ambergris (unii: xtc0d02p6c) (ambergris - unii:xtc0d02p6c), matricaria chamomilla (unii: g0r4ubi2zz) (matricaria chamomilla - unii:g0r4ubi2zz), sus scrofa pituitary gland (unii: l0pfemq1dt) (sus scrofa pituitary gland - unii:l0pfemq1dt), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), anacardium occidentale fruit (unii: 4a10jr4e7e - ​uses: ​(†) homeopathic remedy for feelings of restlessness.

United States - English - NLM (National Library of Medicine)

health masters llc - echinacea angustifolia whole (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), arctium lappa root (unii: 597e9bi3z3) (arctium lappa root - unii:597e9bi3z3), solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), aloe (unii: v5vd430yw9) (aloe - unii:v5vd430yw9), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), mahonia aquifolium root bark (unii: vzj9f3c3sb) (berberis aquifolium root bark - unii:vzj9f3c3sb), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3), glycyrrhiza glabra (unii: 2788z9758h) (glycyrrhiza glabra - unii:2788z9758h), centella asiatica (unii: 7m867g6t1u) (centella asiatica - unii:7m867g6t1u), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), iris versicolor root (unii: x43d4l3dqc) (iris versicolor root - unii:x43d4l3dqc), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), ruta graveolens flowering top (unii: n94c2u587s) (ruta graveolens flowering top - unii:n94c2u587s), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), thyroid, bovine (unii: mn18otn73w) (thyroid, bovine - unii:mn18otn73w) - formulated for symptoms associated with low energy, fatigue and mild stress. formulated for symptoms associated with low energy, fatigue and mild stress.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - milk thistle (unii: u946sh95ee) (milk thistle - unii:u946sh95ee), helianthemum canadense (unii: 46g3w789q3) (helianthemum canadense - unii:46g3w789q3), solanum dulcamara top (unii: kps1b1162n) (solanum dulcamara top - unii:kps1b1162n), galium aparine whole (unii: z4b6561488) (galium aparine - unii:z4b6561488), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), hydrochloric acid (unii: qtt17582cb) (hydrochloric acid - unii:qtt17582cb), estrone (unii: 2di9ha706a) (estrone - unii:2di9ha706a), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), ailanthus altissima flowering twig (unii: 8p29o5p7xu) (ailanthus altissima flowering twig - unii:8p29o5p7xu), barium chloride dihydrate (unii: el5gj3u77e) (barium cation - unii:v645272hln), cadmium (unii: 00bh33gngh) (cadmium - unii:00bh33gngh), ceanothus americanus leaf (unii: 25b1y14t8n) (ceanothus americanus leaf - unii:25b1y14t8n), anamirta cocculus seed (unii: 810258w28u) (anamirta cocculus seed - unii:810258w28u), iridium (unii: 44448s9773) (iridium - unii:44448s9773), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), crotalus durissus terrificus venom (unii: 2xf6i0446g) (crotalus durissus terrificus venom - unii:2xf6i0446g) - ailanthus glandulosus - fever, aqua marina - headache, baryta muriatica - fatigue, cadmium metallicum - fatigue, calcarea carbonica – lack of appetite, carduus marianus - rash, ceanothus americanus - chills, cinchona officinalis – weak muscles, cistus canadensis - fever, cocculus indicus – sore muscles, crotalus cascavella – lack of appetite, dulcamara – weak muscles, folliculinum - rash, galium aparine – sore throat, iridium metallicum - chills, magnesia muriatica – sore muscles, muriaticum acidum – weak muscles, natrum sulphuricum - headache, thuja occidentalis – sore muscles, viscum album - fatigue • for the temporary relief of symptoms including: • fever • fatigue • lack of appetite • rash • sore throat • weakness muscles • sore muscles • chills • headaches. these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

terravitals llc - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), coffea arabica fruit (unii: hox6bek27q) (coffea arabica fruit - unii:hox6bek27q), antimony potassium tartrate (unii: dl6oz476v3) (antimony cation (3+) - unii:069647rpt5), veratrum album root (unii: qns6w5us1z) (veratrum album root - unii:qns6w5us1z), arnica montana whole (unii: o80ty208zw) (arnica montana whole - unii:o80ty208zw), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956) - active ingredients** .............................…..............................….purpose arnica montana 30c hpus.....painful pressure middle and dorsal spine antimonium tartaricum 30c hpus…....... pain between shoulder blades cimicifuga racemosa 30c hpus............................................dorsal pain coffea cruda 30c hpus...................pain, pressure on small of the back crotalus horridus 6c hpus…..................................tensive pain on back veratrum album 30c hpus....................pain on scapular region of back 'hpus' indicates that this ingredient is officially included in the homeopathic pharmacopoeia of the united states **'c' is homeopathic dilution. uses* for temporary relief of pain on sides of neck and nape due to minor muscle strain. **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. directions: adults and adolescents 12 and over: dissolve 1-2 pellets in mouth at the onset of symptoms, repeat every 1- 6 hours as needed do no

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), hops (unii: 01g73h6h83) (hops - unii:01g73h6h83), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), cortisone acetate (unii: 883wkn7w8x) (cortisone - unii:v27w9254fz), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), thyroid (unii: 6rv024oauq) (sus scrofa thyroid - unii:6rv024oauq), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), convallaria majalis (unii: qhh4hvf5qe) (convallaria majalis - unii:qhh4hvf5qe), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), sepia officinalis juice (unii: qdl83wn8c2) (sepia officinalis juice - unii:qdl83wn8c2), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn) - adrenalinum - fatigue, aralia quinquefolia – nervous exhaustion, arsenicum album - anxiety, calcarea carbonica - forgetfulness, convallaria majalis – nervous exhaustion, cortisone aceticum - forgetfulness, crotalus horridus - fatigue, ferrum metallicum - anxiety, humulus lupulus – nervous exhaustion, nux vomica - forgetfulness, phosphoricum acidum - fatigue, phosphorus - anxiety, selenium metallicum - anxiety, sepia – nervous exhaustion, thyroidinum - fatigue. • for the temporary relief of symptoms including: • fatigue  • nervous exhaustion • anxiety  • forgetfulness these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

king bio inc. - equal volumes of each hpus** ingredient in 10x, 30x, and 1lm potencies., arsenicum album, bufo rana, causticum, chamomilla, crotalus horridus, digitalis purpurea, lachesis mutus, lilium tigrinum, pulsatilla, rhus tox, sulphur, tarentula hispana, viscum album, zincum metallicum., hpus indicates the active ingredients are in the official homeopathic pharmacopeia of the united states., reference image:restless leg.jpg - for symptoms of restless legs, often worse at night: urge to move the legs  heaviness  muscle stiffness uneasiness in legs  leg cramps  burning sensation twitching, drawing, jerking legs as per various homeopathic materia medicas. claims based on traditional homeopathic practice, not accepted medical evidence. these uses have not been evaluated by the fda, and product has not been clinically tested. reference image:restless leg.jpg equal volumes of each hpus** ingredient in 10x, 30x, and 1lm potencies. arsenicum album................... restlessness, spasms, leg cramps bufo rana.................................................................stiffness causticum ............................................. restless legs at night chamomilla ................................................cramps, leg aches crotalus horridus ..................................jerking leg movements digitalis purpurea ...................................heavy feeling in limbs lachesis mutus ...............................c

Canada - English - Health Canada

pfizer canada ulc - pentazocine (pentazocine lactate) - solution - 30mg - pentazocine (pentazocine lactate) 30mg - opiate partial agonists

United States - English - NLM (National Library of Medicine)

emd serono, inc. - tepotinib hydrochloride (unii: vy5yx2tq1f) (tepotinib - unii:1ijv77ei07) - tepmetko is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (nsclc) harboring mesenchymal-epithelial transition (met ) exon 14 skipping alterations. none. risk summary based on findings in animal studies and the mechanism of action [see clinical pharmacology (12.1)], tepmetko can cause fetal harm when administered to a pregnant woman. there are no available data on the use of tepmetko in pregnant women. oral administration of tepotinib to pregnant rabbits during the period of organogenesis resulted in malformations (teratogenicity) and anomalies at maternal exposures less than the human exposure based on area under the curve (auc) at the 450 mg daily clinical dose (see data) . advise pregnant women of the potential risk to a fetus. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data animal data in embryo-fetal development studies, pregnant rabbits received oral doses of 0.5, 5, 25, 50, 150, or 450 mg/kg tepotinib hydrochloride hydrate daily during organogenesis. severe maternal toxicity occurred at the 450 mg/kg dose (approximately 0.75 times the human exposure at the 450 mg clinical dose). at 150 mg/kg (approximately 0.5 times the human exposure by auc at the 450 mg clinical dose), two animals aborted and one animal died prematurely; mean fetal body weight was also decreased. a dose-dependent increase of skeletal malformations, including malrotations of fore and/or hind paws with concomitant misshapen scapula and/or malpositioned clavicle and/or calcaneous and/or talus, occurred at doses ≥ 5 mg/kg (approximately 0.003 times the human exposure by auc at the 450 mg clinical dose); there was also an incidence of spina bifida at the 5 mg/kg dose level. risk summary there are no data regarding the secretion of tepotinib or its metabolites in human milk or its effects on the breastfed infant or milk production. advise women not to breastfeed during treatment with tepmetko and for one week after the last dose. based on animal data, tepmetko can cause malformations at doses less than the human exposure based on auc at the 450 mg clinical dose [see use in specific populations (8.1)] . pregnancy testing verify pregnancy status in females of reproductive potential prior to initiating tepmetko [see use in specific populations (8.1)] . contraception females advise females of reproductive potential to use effective contraception during tepmetko treatment and for one week after the last dose. males advise male patients with female partners of reproductive potential to use effective contraception during tepmetko treatment and for one week after the last dose. the safety and efficacy of tepmetko in pediatric patients have not been established. of 313 patients with nsclc positive for met ex14 skipping alterations in vision who received 450 mg tepmetko once daily, 79% were 65 years or older, and 41% were 75 years or older. no clinically important differences in safety or efficacy were observed between patients aged 65 years or older and younger patients. no dosage modification is recommended in patients with mild or moderate renal impairment (creatinine clearance [clcr] 30 to 89 ml/min, estimated by cockcroft-gault). the recommended dosage has not been established for patients with severe renal impairment (clcr < 30 ml/min) [see clinical pharmacology (12.3)]. no dosage modification is recommended in patients with mild (child pugh class a) or moderate (child pugh class b) hepatic impairment. the pharmacokinetics and safety of tepotinib in patients with severe hepatic impairment (child pugh class c) have not been studied [see clinical pharmacology (12.3)] .